Check Y. Quon

1.1k total citations
38 papers, 818 citations indexed

About

Check Y. Quon is a scholar working on Pharmacology, Analytical Chemistry and Molecular Biology. According to data from OpenAlex, Check Y. Quon has authored 38 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Analytical Chemistry and 6 papers in Molecular Biology. Recurrent topics in Check Y. Quon's work include Analytical Methods in Pharmaceuticals (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and HIV/AIDS drug development and treatment (5 papers). Check Y. Quon is often cited by papers focused on Analytical Methods in Pharmaceuticals (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and HIV/AIDS drug development and treatment (5 papers). Check Y. Quon collaborates with scholars based in United States and Spain. Check Y. Quon's co-authors include Herman F. Stampfli, Richard J. Gorczynski, Carolyn Sidor, Robert D. Reynolds, L E Diamond, Dona Alberti, Kyle D. Holen, Amyé Tevaarwerk, Glenn Liu and George Wilding and has published in prestigious journals such as Clinical Cancer Research, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Check Y. Quon

36 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Check Y. Quon United States 15 186 149 138 118 94 38 818
James C. Kisicki United States 17 146 0.8× 70 0.5× 60 0.4× 89 0.8× 77 0.8× 28 789
M. M. Reidenberg United States 12 133 0.7× 80 0.5× 56 0.4× 62 0.5× 78 0.8× 27 659
Phillip A. Reece Australia 17 246 1.3× 78 0.5× 82 0.6× 110 0.9× 164 1.7× 36 886
Peter Seideman Sweden 21 119 0.6× 90 0.6× 40 0.3× 82 0.7× 61 0.6× 49 1.1k
N. Christophidis Australia 16 201 1.1× 99 0.7× 61 0.4× 63 0.5× 196 2.1× 34 1.1k
Peter Zannikos United States 19 215 1.2× 77 0.5× 95 0.7× 114 1.0× 204 2.2× 57 1.0k
C J Bowmer United Kingdom 19 339 1.8× 84 0.6× 105 0.8× 195 1.7× 177 1.9× 68 1.1k
A. H. J. Scaf Netherlands 17 163 0.9× 139 0.9× 100 0.7× 94 0.8× 127 1.4× 37 717
M S Yates United Kingdom 16 201 1.1× 112 0.8× 38 0.3× 59 0.5× 84 0.9× 56 898
Sunny Chapel United States 16 130 0.7× 76 0.5× 164 1.2× 162 1.4× 100 1.1× 45 991

Countries citing papers authored by Check Y. Quon

Since Specialization
Citations

This map shows the geographic impact of Check Y. Quon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Check Y. Quon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Check Y. Quon more than expected).

Fields of papers citing papers by Check Y. Quon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Check Y. Quon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Check Y. Quon. The network helps show where Check Y. Quon may publish in the future.

Co-authorship network of co-authors of Check Y. Quon

This figure shows the co-authorship network connecting the top 25 collaborators of Check Y. Quon. A scholar is included among the top collaborators of Check Y. Quon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Check Y. Quon. Check Y. Quon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tevaarwerk, Amyé, Kyle D. Holen, Dona Alberti, et al.. (2009). Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies. Clinical Cancer Research. 15(4). 1460–1465. 108 indexed citations
2.
Matei, Daniela, Jeanne M. Schilder, Gregory P. Sutton, et al.. (2009). Activity of 2 methoxyestradiol (Panzem® NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial. Gynecologic Oncology. 115(1). 90–96. 88 indexed citations
3.
Molinoff, Perry B., A. M. Shadiack, Dennis Earle, L E Diamond, & Check Y. Quon. (2003). PT‐141: A Melanocortin Agonist for the Treatment of Sexual Dysfunction. Annals of the New York Academy of Sciences. 994(1). 96–102. 72 indexed citations
4.
Fossler, Michael J., William F. Ebling, David M. Kornhauser, et al.. (2002). Integrated Pharmacokinetic/Pharmacodynamic Model of XV459, a Potent and Specific GPIIb/IIIa Inhibitor, in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 42(12). 1326–1334. 7 indexed citations
5.
Lai, Chii‐Ming, Bernice L. Brogdon, Check Y. Quon, & Henry J. Pieniaszek. (1994). Determination of DuP 128, an ACAT inhibitor and its sulphoxide and sulphone metabolites in human plasma by liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 12(9). 1163–1172. 1 indexed citations
6.
Wong, Y. Nancy, et al.. (1994). The pharmacokinetics and metabolism of DuP 532, a non‐peptide angiotensin II receptor antagonist, in rats and dogs. Biopharmaceutics & Drug Disposition. 15(1). 53–63. 5 indexed citations
7.
King, Shang‐Ying P., David B. Adams, Violante E. Currie, et al.. (1994). Protein binding of brequinar in the plasma of healthy donors and cancer patients and analysis of the relationship between protein binding and pharmacokinetics in cancer patients. Cancer Chemotherapy and Pharmacology. 35(2). 101–108. 5 indexed citations
8.
Christ, David D., et al.. (1994). The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.. Journal of Pharmacology and Experimental Therapeutics. 268(3). 1199–1205. 44 indexed citations
9.
Wong, Y. Nancy, et al.. (1994). A pharmacokinetic evaluation of HIV protease inhibitors, cyclic ureas, in rats and dogs. Biopharmaceutics & Drug Disposition. 15(7). 535–544. 15 indexed citations
10.
Pieniaszek, Henry J., et al.. (1994). The effect of hepatic disease on the disposition of moricizine in humans. Biopharmaceutics & Drug Disposition. 15(3). 243–252. 6 indexed citations
11.
Stampfli, Herman F., Christine Person, Shiew‐Mei Huang, & Check Y. Quon. (1994). Pharmacokinetics of the inodilator XB513 in mice, rats, guinea pigs, rabbits, dogs, and monkeys. Biopharmaceutics & Drug Disposition. 15(9). 789–793. 1 indexed citations
12.
13.
Chorvat, Robert J., Lawrence A. Black, Vasant Ranade, et al.. (1993). Mono- and bis(aminomethyl)phenylacetic acid esters as short-acting antiarrhythmic agents. 2. Journal of Medicinal Chemistry. 36(17). 2494–2498. 5 indexed citations
14.
Stone, J. Gilbert, et al.. (1990). Influence of temperature on in vitro metabolism of esmolol. Journal of Cardiothoracic Anesthesia. 4(6). 704–706. 11 indexed citations
15.
Stampfli, Herman F., et al.. (1989). TEMPERATURE DEPENDENCE OF IN-VITRO METABOLISM OF ESMOLOL. Anesthesiology. 71(Supplement). A513–A513. 1 indexed citations
16.
Stout, David M., Lawrence A. Black, W. L. Matier, et al.. (1989). Ester derivatives of 2,6-bis(1-pyrrolidinylmethyl)-4-benzamidophenol as short-acting antiarrhythmic agents. 1. Journal of Medicinal Chemistry. 32(8). 1910–1913. 5 indexed citations
17.
Quon, Check Y., et al.. (1988). Species differences in the stereoselective hydrolysis of esmolol by blood esterases.. Drug Metabolism and Disposition. 16(3). 425–428. 49 indexed citations
18.
Gerber, Nicolas U., D C Mays, Atul Laddu, et al.. (1988). Safety, Tolerance and Pharmacokinetics of Intravenous Doses of the Phosphate Ester of 3‐Hydroxymethyl‐5,5‐Diphenylhydantoin: A New Prodrug of Phenytoin. The Journal of Clinical Pharmacology. 28(11). 1023–1032. 50 indexed citations
19.
Quon, Check Y. & Richard J. Gorczynski. (1987). Pharmacodynamics and onset of action of esmolol in anesthetized dogs. Journal of Cardiothoracic Anesthesia. 1(1). 87–87. 10 indexed citations
20.
Quon, Check Y. & Herman F. Stampfli. (1985). Biochemical properties of blood esmolol esterase.. Drug Metabolism and Disposition. 13(4). 420–424. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James C. Kisicki Breakdown of academic impact, for papers by M. M. Reidenberg Breakdown of academic impact, for papers by Phillip A. Reece Breakdown of academic impact, for papers by Peter Seideman Breakdown of academic impact, for papers by N. Christophidis Breakdown of academic impact, for papers by Peter Zannikos Breakdown of academic impact, for papers by C J Bowmer Breakdown of academic impact, for papers by A. H. J. Scaf Breakdown of academic impact, for papers by M S Yates Breakdown of academic impact, for papers by Sunny Chapel
Rankless by CCL
2026